Articles

Quick View: Abbvie’s Expansion In Singapore Will Bolster Its Global Biopharmaceutical Supply Capabilities

Pharmaceuticals / Singapore / Thu 01 Feb, 2024

The Latest: On January 29 2024, AbbVie announced a major expansion initiative for its manufacturing operations in Singapore with an investment of USD223mn. This strategic infusion of capital is intended to bolster AbbVie's worldwide production network with an emphasis on the development of biologic drugs. The planned expansion will not only

Read More

UK Inflation To Fall Below Target By End 2024

Country Risk / United Kingdom / Thu 01 Feb, 2024

Key View

  • The Bank of England (BoE) held Bank Rate steady at 5.25% on February 1 2024, marking the fourth rate hold in a row. The BoE has clearly entered a holding pattern, which we expect to extend well into 2024.
  • We anticipate that the BoE will begin to reduce rates in H2 2024, with 75bps of cuts pencilled in by end-year.
  • Although our
Read More

Bulgaria, A Tourism Investment Market To Watch

Tourism / Bulgaria / Thu 01 Feb, 2024

Key View: We highlight Bulgaria as a market to watch for tourism investment over the medium term (2024-2028). We estimate that the market’s total tourist arrivals made a full recovery to their pre-pandemic levels in 2023 and will grow by an annual average of 3.7% over the medium term to reach a projected 15.5mn in 2028. We highlight investment in

Read More

Norwegian Krone To Find Modest Support In Hawkish Norges Bank

Country Risk / Norway / Wed 31 Jan, 2024

Key View

  • We expect the NOK to appreciate gradually over the course of 2024 even as it faces short-term headwinds as a favourable interest rate differential and lower NOK sales by Norges Bank support the unit.
  • Our expectation for a favourable interest rate differential between Norges Bank and other central banks drives our bullish forecast for
Read More

Saudi Arabia’s Growth Will Rebound In 2024

Country Risk / Saudi Arabia / Wed 31 Jan, 2024

Key View

  • Saudi Arabia's GDP will recover from a contraction of 0.9% in 2023 to positive growth of 2.4% in 2024, with the non-oil economy doing much of the heavy lifting in tandem with a normalisation in oil production.
  • Steady oil production, sluggish demand for Saudi non-oil exports and steady import growth will see net exports remain a drag
Read More

Multinational Drugmakers Will Increase Partnerships With Domestic Firms To Deepen Market Penetration In Mainland China

Pharmaceuticals / China / Wed 31 Jan, 2024

Key View

  • Foreign pharmaceutical companies will continue to cast a vote of confidence in Mainland China's medicine market and will expand investment.
  • We believe in 2024 multinational companies will increasingly partner with local companies in Mainland China to leverage the synergies of both foreign and domestic companies.
  • Mainland China's
Read More
Download Indicator Summary
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.

Clearbit Form
 

Thank you. Your download link will be emailed to you shortly.

Download Now
 

Thank you. Your download link will be emailed to you shortly.